A Multicenter, Double-Blind, Comparative Study of MK0991 (Caspofungin) Versus Micafungin in Adult Japanese Patients With Deep-seated Candida or Aspergillus Infections
Phase of Trial: Phase III
Latest Information Update: 28 Mar 2017
Price : $35 *
At a glance
- Drugs Caspofungin (Primary) ; Micafungin
- Indications Aspergillosis; Candidiasis
- Focus Adverse reactions
- Sponsors Merck Sharp & Dohme
- 26 Mar 2014 New trial record
- 26 Aug 2010 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 25 Jun 2010 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.